Key considerations include: Disease activity status : Active inflammation may increase susceptibility to adverse effects Nutritional state : Patients already experiencing malabsorption or weight loss may not be appropriate candidates for medications that further reduce appetite Stricture presence : Delayed gastric emptying could theoretically worsen symptoms in patients with bowel narrowing Medication interactions : While subcutaneous semaglutide has minimal effects on most oral drug absorption, specific medications (such as levothyroxine with oral semaglutide/Rybelsus) may require monitoring Hypoglycemia risk : For patients with diabetes using insulin or sulfonylureas, dose reductions of these medications may be needed when starting semaglutide Diabetic retinopathy : Patients with pre-existing diabetic retinopathy should be monitored for worsening eye disease There is currently insufficient evidence to provide definitive guidance, making shared decision-making between patient and healthcare team essential

The treatment actually contains the allergens in question and is designed to retrain your immune system to tolerate a higher threshold of their presence before triggering a reaction.41 Who is Strut Health for
These fluctuations represent water, glycogen, and GI contents, not fat gain
Patients on tirzepatide lost an average of 20.2% of their body weight over 72 weeks, compared to 13.7% with semaglutide.[1] That gap is not small, and for patients in Shreveport asking which medication is the better choice, this study provides the clearest evidence yet
Its not fun at first, but its manageable